- Income Tax Expense (Benefit)
- Effective Income Tax Rate (EITR)
- Components of Deferred Tax Assets and Liabilities
- Deferred Tax Assets and Liabilities, Classification
- Adjustments to Financial Statements: Removal of Deferred Taxes
- Adjusted Financial Ratios: Removal of Deferred Taxes (Summary)
- Adjusted Net Profit Margin
- Adjusted Total Asset Turnover
- Adjusted Financial Leverage
- Adjusted Return on Equity (ROE)
- Adjusted Return on Assets (ROA)
Paying user area
Try for free
Medtronic PLC pages available for free this week:
- Income Statement
- Statement of Comprehensive Income
- Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Solvency Ratios
- Analysis of Reportable Segments
- Present Value of Free Cash Flow to Equity (FCFE)
- Net Profit Margin since 2005
- Return on Equity (ROE) since 2005
- Return on Assets (ROA) since 2005
- Price to Operating Profit (P/OP) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Medtronic PLC for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Income Tax Expense (Benefit)
| 12 months ended: | Apr 24, 2026 | Apr 25, 2025 | Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current tax expense | |||||||||||||
| Deferred tax expense (benefit) | |||||||||||||
| Income tax provision (benefit) |
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).
The total income tax provision exhibits significant volatility over the analyzed period, characterized by a sharp increase peaking in 2023 followed by a period of fluctuation. Total tax obligations rose from 265 million USD in 2021 to a peak of 1,580 million USD in 2023, before ending the period at 1,299 million USD in 2026.
- Current Tax Expense Trends
- A strong upward trajectory is observed in current tax expenses between 2021 and 2023, with figures rising from 726 million USD to a maximum of 1,833 million USD. Following this peak, a moderating trend emerged, with expenses declining to 1,275 million USD in 2025 and remaining relatively stable at 1,268 million USD in 2026.
- Deferred Tax Dynamics
- Deferred tax accounts provided a consistent benefit to the overall tax provision from 2021 through 2025, with benefits ranging from a low of 253 million USD in 2023 to a high of 611 million USD in 2022. A significant structural shift occurred in 2026, where the deferred tax position transitioned from a benefit to an expense of 31 million USD.
- Total Provision Interaction
- The net income tax provision was heavily influenced by the offsetting effect of deferred tax benefits against current tax liabilities. The peak provision in 2023 resulted from the convergence of the highest current tax expense and one of the lowest deferred tax benefits. By 2026, the total provision increased to 1,299 million USD, driven largely by the reversal of the deferred tax benefit which had historically served to lower the net tax burden.
Effective Income Tax Rate (EITR)
| Apr 24, 2026 | Apr 25, 2025 | Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | ||
|---|---|---|---|---|---|---|---|
| U.S. federal statutory tax rate | |||||||
| Effective tax rate |
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).
The analysis of income tax figures reveals significant volatility in the effective tax rate relative to a constant U.S. federal statutory tax rate of 21.00% over the analyzed period.
- Initial Period of Sub-Statutory Taxation (2021-2022)
- During the fiscal years ending in 2021 and 2022, the effective tax rate remained substantially below the statutory benchmark, recording 6.80% and 8.30%, respectively. This indicates a period of high tax efficiency, likely driven by the application of significant tax credits or favorable jurisdictional tax differentials.
- Peak Volatility and Statutory Overages (2023-2024)
- A sharp upward trend is observed starting in 2023, where the effective tax rate surged to 29.50%, exceeding the statutory rate by 8.5 percentage points. While the rate decreased to 23.40% in 2024, it continued to remain above the 21.00% federal benchmark, reflecting a period of increased tax burden or the reversal of prior tax advantages.
- Trend Toward Normalization (2025-2026)
- The final two years show a movement toward stabilization. The effective tax rate declined to 16.60% in 2025 before rising to 21.20% in 2026. This final value demonstrates a near-complete convergence with the U.S. federal statutory tax rate, suggesting a normalization of the company's tax obligations.
Components of Deferred Tax Assets and Liabilities
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).
The overall net tax asset position demonstrates a consistent upward trajectory, increasing from 2,897 million US dollars in April 2021 to 4,742 million US dollars by April 2026. This growth is primarily driven by an expansion in gross deferred tax assets, which more than doubled over the period, although this growth was partially offset by a substantial increase in valuation allowances and deferred tax liabilities.
- Growth of Gross Deferred Tax Assets
- Gross deferred tax assets rose from 8,754 million US dollars in 2021 to a peak of 18,277 million US dollars in 2024, before settling at 17,548 million US dollars in 2026. The primary catalyst for this increase was the significant rise in net operating loss, capital loss, and credit carryforwards, which grew from 6,114 million US dollars to 11,076 million US dollars over the analyzed period. Additionally, the capitalization of research and development showed a strong upward trend, increasing from 408 million US dollars in 2021 to 1,340 million US dollars in 2026, further contributing to the asset base.
- Application of Valuation Allowances
- A significant portion of the gross deferred tax assets is offset by a valuation allowance, indicating a conservative accounting approach regarding the realizability of these assets. The valuation allowance expanded from 5,822 million US dollars in 2021 to 12,338 million US dollars in 2026. The close correlation between the growth of gross deferred tax assets and the valuation allowance suggests that a substantial proportion of the net operating loss carryforwards may not be fully utilized in the immediate future.
- Analysis of Deferred Tax Liabilities
- Deferred tax liabilities increased from 846 million US dollars in 2021 to 1,834 million US dollars in 2026. This growth is predominantly attributed to the increase in deferred taxes related to intangible assets, which moved from a liability of 320 million US dollars in 2021 to 1,124 million US dollars in 2026. Other liabilities, such as right-of-use leases, also showed a steady increase, rising from 102 million US dollars to 178 million US dollars over the same period.
- Net Tax Position and Liquidity Components
- The net deferred tax asset position improved from 2,086 million US dollars in 2021 to 3,376 million US dollars in 2026. This strengthens the total tax asset position when combined with prepaid income taxes and income tax receivables. Prepaid income taxes grew from 458 million US dollars to 701 million US dollars, while income tax receivables increased from 353 million US dollars to 665 million US dollars, indicating a higher volume of recoverable tax payments and credits.
Deferred Tax Assets and Liabilities, Classification
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).
An analysis of the tax-related accounts reveals a consistent expansion of the total tax asset position over the period ending April 2026. Total tax assets grew from US$ 3,169 million in 2021 to a peak of US$ 4,040 million in 2025, before a slight correction to US$ 3,943 million in 2026. This growth is primarily driven by a steady accumulation of deferred tax assets and an increase in current tax-related receivables.
- Deferred Tax Asset and Liability Trends
- Deferred tax assets exhibited a sustained upward trajectory for the majority of the period, rising from US$ 3,114 million in 2021 to US$ 3,907 million in 2025. In contrast, deferred tax liabilities demonstrated a continuous and significant decline, falling from US$ 1,028 million in 2021 to US$ 362 million by April 2026. This divergence indicates a substantial strengthening of the net deferred tax asset position, which grew from US$ 2,086 million in 2021 to US$ 3,375 million in 2026.
- Current Tax Asset Composition
- Prepaid income taxes and income tax receivables both trended upward over the analyzed timeframe. Prepaid taxes increased from US$ 458 million in 2021 to US$ 701 million in 2026. Income tax receivables showed more fluctuation, reaching US$ 665 million in 2026 after a period of volatility between 2022 and 2024. These components, along with other current assets which grew from US$ 756 million to US$ 1,160 million, indicate an increase in short-term resources allocated to tax-related accounts.
- Net Tax Position and Classification
- The overall financial profile shows a shift toward a dominant net asset position regarding income taxes. The consistent reduction in deferred tax liabilities, coupled with the growth in deferred tax assets, suggests a strategic or operational shift resulting in increased future tax benefits. The classification of these assets indicates that while a portion remains current through receivables and prepayments, the vast majority of the tax benefit is deferred, providing long-term balance sheet support.
Adjustments to Financial Statements: Removal of Deferred Taxes
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).
An analysis of the financial adjustments related to the removal of deferred taxes reveals a consistent divergence between reported and adjusted financial positions from 2021 through 2026. The systematic removal of these tax items results in a reduction of total assets, total liabilities, and shareholders' equity, providing a view of the balance sheet devoid of deferred tax accounting effects.
- Impact on Asset and Liability Structure
- Reported total assets consistently exceed adjusted total assets across the entire period. This variance grew from 3,114 million USD in 2021 to a peak of 3,907 million USD in 2025, before settling at 3,737 million USD in 2026. Concurrently, a contrasting trend is observed in liabilities; the gap between reported and adjusted total liabilities narrowed steadily from 1,028 million USD in 2021 to 362 million USD in 2026, indicating a reduction in the relative weight of deferred tax liabilities over time.
- Shareholders' Equity Variance
- The adjustment process results in a persistent decrease in shareholders' equity. The difference between reported and adjusted equity expanded from 2,086 million USD in 2021 to 3,504 million USD in 2025, reflecting the net effect of removing deferred tax assets and liabilities. While reported equity experienced a decline between 2022 and 2025, adjusted equity followed a similar trajectory, reaching its lowest point in 2025 at 44,520 million USD before recovering in 2026.
- Net Income Volatility
- Adjusted net income exhibits significant fluctuations relative to reported figures. Between 2021 and 2025, adjusted net income remained consistently lower than reported net income, suggesting that deferred tax credits or reversals typically bolstered the reported bottom line during these years. However, a reversal of this pattern occurred in 2026, where adjusted net income of 4,832 million USD exceeded reported net income of 4,801 million USD, indicating a shift in the nature of the tax adjustments for that fiscal period.
Medtronic PLC, Financial Data: Reported vs. Adjusted
Adjusted Financial Ratios: Removal of Deferred Taxes (Summary)
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).
An analysis of the financial ratios between 2021 and 2026 reveals a consistent variance between reported and adjusted figures resulting from the removal of deferred taxes. While both sets of metrics generally follow parallel trajectories, the adjustment typically exerts a downward pressure on profitability and return ratios in the earlier periods, while slightly increasing leverage and asset turnover across the entire timeframe.
- Profitability and Return Margins
- Reported net profit margins exhibited significant volatility, peaking at 15.90% in 2022 before stabilizing around 13.20% by 2026. Adjusted net profit margins remained consistently lower than reported figures from 2021 to 2024, though this gap narrowed significantly by 2026, where the adjusted margin reached 13.29%.
- A similar pattern is observed in Return on Equity (ROE) and Return on Assets (ROA). In the initial years, the removal of deferred taxes reduced both ROE and ROA. However, a reversal occurs in the final two years of the period; by 2026, the adjusted ROE (10.48%) and adjusted ROA (5.41%) exceed their reported counterparts (9.71% and 5.16%, respectively), suggesting a shift in the impact of deferred tax accounting on the equity and asset bases.
- Operational Efficiency and Capital Structure
- Total asset turnover shows a steady upward trend in both reported and adjusted metrics. The adjusted total asset turnover is consistently higher than the reported ratio, rising from 0.33 in 2021 to 0.41 by 2026. This indicates that the removal of deferred taxes effectively reduces the asset base relative to revenue, thereby improving the efficiency ratio.
- Financial leverage remains relatively stable but reflects a consistent increase when adjusted for deferred taxes. Reported leverage fluctuated between 1.73 and 1.91, while adjusted leverage remained higher throughout the period, peaking at 1.97 in 2025. This suggests that deferred tax items provide a buffering effect on the reported equity, and their removal results in a higher perceived leverage profile.
Overall, the data indicates that while deferred taxes inflate reported profitability and lower reported leverage in the short term, the long-term trend toward 2026 shows a convergence where adjusted returns eventually outperform reported returns.
Medtronic PLC, Financial Ratios: Reported vs. Adjusted
Adjusted Net Profit Margin
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).
2026 Calculations
1 Net profit margin = 100 × Net income attributable to Medtronic ÷ Net sales
= 100 × ÷ =
2 Adjusted net profit margin = 100 × Adjusted net income attributable to Medtronic ÷ Net sales
= 100 × ÷ =
The financial performance from 2021 through 2026 is characterized by a cyclical pattern of profitability, marked by a significant peak in 2022, a subsequent contraction period reaching its nadir in 2024, and a recovery phase extending through 2026.
- Adjusted Net Profit Margin Analysis
- The adjusted net profit margin experienced notable volatility, rising from 10.44% in 2021 to a peak of 13.97% in 2022. A downward trend followed, with the margin declining to 11.22% in 2023 and reaching a low of 9.73% in 2024. A recovery is observed in the final two years, with the margin expanding to 12.89% in 2025 and finishing at 13.29% in 2026.
- Reported vs. Adjusted Net Income Variance
- Between 2021 and 2025, reported net income remained consistently higher than adjusted net income, indicating that non-recurring items or specific accounting adjustments had a positive impact on the reported bottom line. This trend reversed in 2026, where adjusted net income of 4,832 million USD slightly exceeded the reported figure of 4,801 million USD, suggesting a shift in the nature of the adjustments affecting the financial statements.
- Convergence of Profitability Metrics
- A strong correlation exists between reported and adjusted net profit margins, as both metrics mirrored the same trajectory of growth, decline, and recovery. By 2026, the gap between the reported margin (13.20%) and the adjusted margin (13.29%) narrowed significantly, reflecting a convergence between GAAP reported performance and adjusted operational results.
Adjusted Total Asset Turnover
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).
2026 Calculations
1 Total asset turnover = Net sales ÷ Total assets
= ÷ =
2 Adjusted total asset turnover = Net sales ÷ Adjusted total assets
= ÷ =
An analysis of asset utilization from April 2021 to April 2026 reveals a consistent improvement in operational efficiency, characterized by a steady increase in asset turnover ratios despite fluctuations in the total asset base.
- Total Asset Trends
- Reported total assets experienced a gradual decline from US$ 93,083 million in 2021 to a low of US$ 89,981 million in 2024, followed by a recovery to US$ 93,028 million by 2026. Adjusted total assets followed a similar trajectory, contracting from US$ 89,969 million in 2021 to US$ 86,420 million in 2024 before trending upward to US$ 89,291 million in 2026. The persistent gap between reported and adjusted assets suggests consistent balance sheet adjustments across the observed period.
- Asset Turnover Performance
- A positive trend is observed in both reported and adjusted total asset turnover. The reported ratio rose from 0.32 in 2021 to 0.39 in 2026, with a minor stagnation occurring between 2022 and 2023. The adjusted total asset turnover demonstrates more consistent growth, climbing from 0.33 in 2021 to 0.41 in 2026.
- Comparative Efficiency Insights
- The adjusted total asset turnover consistently exceeds the reported ratio throughout the six-year period. The widening of this margin toward 2026 indicates that when non-operating or adjusting factors are removed, the underlying efficiency of the asset base in generating revenue is improving at a faster rate than the reported figures suggest.
Overall, the data indicates a successful optimization of assets. The increase in turnover ratios occurring simultaneously with the recovery of the asset base since 2024 suggests that growth in revenue is outpacing the growth in assets, leading to higher overall capital productivity.
Adjusted Financial Leverage
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).
2026 Calculations
1 Financial leverage = Total assets ÷ Shareholders’ equity
= ÷ =
2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted shareholders’ equity
= ÷ =
An analysis of the financial structure from April 2021 to April 2026 reveals fluctuating trends in asset valuation and equity levels, resulting in a cyclical movement in financial leverage. Adjusted figures consistently reflect a more conservative asset and equity base compared to reported figures, which consequently elevates the adjusted financial leverage ratios throughout the period.
- Total Asset Trends
- Reported total assets experienced a decline from 93,083 million US$ in 2021 to a low of 89,981 million US$ in 2024, before recovering to 93,028 million US$ by 2026. Adjusted total assets followed a nearly identical trajectory, remaining consistently lower than reported figures, which indicates a persistent downward adjustment across the six-year span.
- Shareholders' Equity Dynamics
- A general downward trend in equity is observable from 2021 through 2025. Reported shareholders' equity decreased from 51,428 million US$ in 2021 to a low of 48,024 million US$ in 2025, followed by a slight recovery to 49,463 million US$ in 2026. Adjusted shareholders' equity mirrors this contraction, reaching its lowest point of 44,520 million US$ in 2025, further widening the gap between reported and adjusted equity levels.
- Financial Leverage Analysis
- Financial leverage ratios exhibit a fluctuating pattern, with a notable peak in 2025. Reported financial leverage decreased from 1.81 in 2021 to 1.73 in 2022, before rising to a peak of 1.91 in 2025 and slightly moderating to 1.88 in 2026. The adjusted financial leverage consistently tracks higher than the reported ratio, peaking at 1.97 in 2025. The consistent variance between reported and adjusted leverage suggests that the adjustments to assets and equity increase the perceived financial leverage of the organization.
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).
2026 Calculations
1 ROE = 100 × Net income attributable to Medtronic ÷ Shareholders’ equity
= 100 × ÷ =
2 Adjusted ROE = 100 × Adjusted net income attributable to Medtronic ÷ Adjusted shareholders’ equity
= 100 × ÷ =
The financial performance from April 2021 through April 2026 is characterized by fluctuations in net income coupled with a general contraction in shareholders' equity, which has collectively influenced the trajectory of the return on equity (ROE).
- Adjusted Return on Equity (ROE) Trends
- The adjusted ROE exhibits a cyclical pattern over the six-year period. Starting at 6.37% in April 2021, the ratio peaked at 8.84% in 2022 before experiencing a decline to 6.67% by April 2024. A significant recovery is observed in the final two years, with the ratio climbing to 9.71% in 2025 and reaching a period high of 10.48% in April 2026. This upward trajectory in the latter years is driven by a simultaneous increase in adjusted net income and a reduction in the adjusted equity base.
- Net Income and Equity Correlation
- Adjusted net income showed volatility, peaking in April 2022 at 4,428 million US$ and April 2026 at 4,832 million US$. Concurrently, adjusted shareholders' equity followed a general downward trend, decreasing from 49,342 million US$ in 2021 to a low of 44,520 million US$ in 2025, before a slight recovery to 46,087 million US$ in 2026. The contraction of the equity base has served to amplify the impact of net income growth on the ROE calculation.
- Comparison of Reported and Adjusted Metrics
- In the early years of the analysis (2021-2024), the adjusted ROE remained consistently lower than the reported ROE, indicating that adjustments to net income and equity exerted a downward pressure on the return metric. However, a shift occurred in April 2025, where reported and adjusted ROE converged at 9.71%. By April 2026, the adjusted ROE of 10.48% surpassed the reported ROE of 9.71%, suggesting that the exclusions applied for the adjusted figures became favorable to the profitability ratio in the final period.
Overall, the increase in efficiency as measured by adjusted ROE toward the end of the period is attributable to stronger adjusted net income figures coinciding with a lean equity structure compared to the 2021-2022 levels.
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).
2026 Calculations
1 ROA = 100 × Net income attributable to Medtronic ÷ Total assets
= 100 × ÷ =
2 Adjusted ROA = 100 × Adjusted net income attributable to Medtronic ÷ Adjusted total assets
= 100 × ÷ =
The financial performance over the observed period is characterized by volatility in profitability and a relatively stable asset base. A distinct cycle is evident, featuring a performance peak in 2022, a contraction during 2023 and 2024, and a subsequent recovery leading into 2026.
- Net Income Trends
- Both reported and adjusted net income exhibited significant fluctuations. Reported net income reached a peak of US$ 5,039 million in 2022 before declining to a low of US$ 3,676 million by 2024. A recovery trend followed, with reported net income climbing to US$ 4,801 million by 2026. Adjusted net income mirrored this volatility, peaking in 2022 and 2026, with the 2026 figure of US$ 4,832 million representing the highest adjusted profit in the period.
- Asset Base Stability
- Total assets remained relatively consistent, with reported assets fluctuating within a narrow range between US$ 89,981 million and US$ 93,083 million. Adjusted total assets followed a similar trajectory, reaching a minimum of US$ 86,420 million in 2024 before ascending to US$ 89,291 million by 2026.
- Return on Assets (ROA) Performance
- Reported ROA peaked at 5.54% in 2022, dipped to 4.09% in 2024, and recovered to 5.16% by 2026. Adjusted ROA followed a similar pattern but generally remained below reported levels until the final year. By 2026, the adjusted ROA of 5.41% surpassed the reported ROA of 5.16%, indicating that the adjustments applied to net income and assets had a positive impact on the measured efficiency in the final year.
- Reported versus Adjusted Variance
- A persistent gap between reported and adjusted figures suggests the impact of non-recurring items or specific tax adjustments. For the majority of the period, reported net income exceeded adjusted net income. However, this trend reversed in 2026, where adjusted net income (US$ 4,832 million) exceeded reported net income (US$ 4,801 million), shifting the relationship between the two metrics.